BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/26/2026 10:19:30 AM | Browse: 43 | Download: 64
 |
Received |
|
2025-09-28 01:06 |
|
Peer-Review Started |
|
2025-09-28 01:06 |
|
First Decision by Editorial Office Director |
|
2025-10-23 07:35 |
|
Return for Revision |
|
2025-10-23 07:35 |
|
Revised |
|
2025-11-03 16:24 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-08 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-08 05:28 |
|
Articles in Press |
|
2025-12-08 05:28 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-05 01:13 |
|
Publish the Manuscript Online |
|
2026-02-26 10:19 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
From inflammation to precision medicine in colon cancer: Methodological considerations and future directions
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Arunkumar Krishnan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arunkumar Krishnan, Assistant Professor, MD, Senior Scientist, Department of Oncology, Atrium Health Levine Cancer, 1021 Morehead Medical Drive, Charlotte, NC 28204, United States. dr.arunkumar.krishnan@gmail.com |
| Key Words |
Colon cancer; Elderly; Precision medicine; Systemic immune-inflammation index; Lactoferrin; Prognostic biomarkers; Survival; Methodological critique |
| Core Tip |
A study by Zhu SS et al reported that the systemic immune-inflammation index and serum lactoferrin levels predict survival in elderly patients with colon cancer. While promising, the study was limited by a small, single-center cohort, a short follow-up period, and an incomplete adjustment for confounders. Predictive accuracy was only moderate, yet conclusions were overstated. To ensure clinical utility, future research should validate systemic immune-inflammation index and lactoferrin in larger, multicenter studies with longer follow-up, benchmark them against established prognostic indices, and incorporate molecular markers. Such efforts are crucial to establishing reliable, externally validated prognostic tools for the individualized management of older colon cancer patients. |
| Publish Date |
2026-02-26 10:19 |
| Citation |
Krishnan A. From inflammation to precision medicine in colon cancer: Methodological considerations and future directions. World J Gastrointest Surg 2026; 18(2): 114796 |
| URL |
https://www.wjgnet.com/1948-9366/full/v18/i2/114796.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v18.i2.114796 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
